Integra Nutrition
home catalouge client archive contact


OUR R-ALPHA LIPOIC ACID

Benefits

 

žGuaranteed Purity

žBetter Absorption

žEnhanced Bioavailability

žAntioxidant Regenerator

žMetal Chelation

žResearch

žClinically demonstrated effectiveness

žPharmaceutical Manufacturing License

žGood Manufacturing Practices (GMP)

 

In order to be considered a powerful antioxidant, a compound must meet several criteria. In addition to displaying antioxidant features such as radical quenching, metal chelation, interaction with other antioxidants, metabolic regeneration and gene regulation, the substance needs to be bioavailable and safe.  Lipoic acid and its reduced form, dihydrolipoic acid (DHLA), meet all the above criteria and therefore may be considered a complete antioxidant. For comparison, vitamin E, which is regarded as one of the most important biological antioxidants, scavenges only peroxyl radicals in membranes.

 

R-Alpha-Lipoic Acid is a naturally occurring substance that offers health benefits beyond plain nutrition. It plays a pivotal role in cellular metabolism by acting as a coenzyme in energy production and by functioning as an ideal antioxidant.

 

R-Alpha-Lipoic acid also offers protection against the sequelae of diabetes, such as neuropathy, cataract, and cardiovascular disease and ameliorates insulin sensitivity in type II diabetes. In addition, there is evidence that it delays the aging process, improves brain function and memory, stimulates immune function and supports liver health.

 

R vs. S Form

Conventional chemical synthesis of lipoic acid yields a mixture of R- and S-enantiomers. Lipoic acid from Alpha Science is processed in such a way as to yield the active R- isomer only with a purity guaranteed to be higher than 99%.

 

Bioavailability of R- and S- lipoic acid has been studied extensively in humans using single dose administration (1,2,3,4,5). After intravenous administration, there is no difference between R- and S-lipoic acid concentrations in plasma. However, after oral intake of the combined mixture, a higher response is found for R-lipoic acid than for the S-form (3). At least 60% higher for the R-form, which is highly significant.

 

 

Research

Recent research has shown that antioxidants function beyond mere protection from oxidative damage. Oxidants and antioxidants are involved in the regulation of key mechanisms related to metabolism, immunity, arterial function, cell proliferation, aging and cell death. Oxidation and reduction (redox) emerges as the principle underlying mechanism. Thiol antioxidants such as glutathione and lipoic acid appear to play a predominant role in the redox-dependent regulation of numerous cellular targets (6).

 

Research has also concluded that antioxidants, namely lipoic acid, can be of preventive and/or therapeutic benefit for inflammatory disorders.  Lipoic acid plays an additional role in the regulation of genes related to several pathologies that include arteriosclerosis, atherosclerosis, arthritis, cancer, ischemia-reperfusion injury, apoptosis and HIV infection, all involving inflammation. (7,8,9,10,11).

 

Antioxidant Properties of Lipoic Acid

Lipoic acid and its reduced form, DHLA, appear in tissues in free form indicating that lipoic acid is activated metabolically to DHLA in vivo.  DHLA is a strong reductant that can regenerate oxidized antioxidants. Specifically, when antioxidants such as ascorbate, glutathione, coenzyme Q10 and vitamin E scavenge radicals, they become radicals themselves. DHLA can directly and indirectly recycle these substances and “reactivate” them (17,18,13,19). From this came the term “antioxidant network”.  For example, when vitamin E scavenges a peroxyl radical, a vitamin E radical is formed. The vitamin E radical may be reduced at the lipid/water interface by several antioxidants, such as ascorbate, ubiquinol, and reduced glutathione (GSH)(see below). DHLA is able to reduce all these antioxidants and thus regenerate them and therefore take a central position in the antioxidant network. Remarkably, lipoic acid has both water-soluble and membrane-soluble characteristics, enabling it to reduce oxidized antioxidants at the lipid/water interface.

 

The predominant form that interacts with reactive oxygen species is DHLA, but the oxidized form of lipoic acid can also inactivate free radicals. The table below lists broad array of reactive oxygen species scavenged by lipoic acid and DHLA.

 

Table: R-Alpha-Lipoic Acid /Dihydrolipoic Acid (DHLA)—The Most Versatile Antioxidant Pair

 


Scavenged by
Oxidant
Hydrogen peroxide
Singlet oxygen
Hydroxyl radical
Nitric oxide radical
Superoxidc radical
Hypochlorous acid
Peroxynitrite
Peroxyl radical

Lipoic acid
Yes
Yes
Yes
Yes
No
Yes
Yes
No

Dihydrolipoic acid
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes


 

Glutathione Synthesis

As mentioned, treatment with lipoic acid enhances glutathione (GSH) levels in vivo and in vitro (20,21,19,22). Glutathione is the most important water-soluble endogenous antioxidant and is linked to detoxification of xenobiotics, modulation of signal transduction, prostaglandin metabolism, regulation of immune response, control of enzyme activity and peptide hormones, etc. Studies with human cells have provided insights into how lipoic acid increases GSH levels.  Cysteine availability is known as the rate-limiting factor in glutathione synthesis. Lipoic acid is taken up rapidly by the cell and reduced to DHLA, which in turn reduces cystine to cysteine and accelerates the biosynthesis of GSH (23).

 

Metal Chelation

Transition metals such as iron, copper, mercury, or cadmium can induce free radical damage in biological systems by catalyzing decomposition of hydroperoxides and generate highly toxic hydroxyl radicals. Lipoic acid and DHLA may exhibit antioxidant activity by metal chelating (13), which helps explain the usefulness of lipoic acid for detoxification in heavy metal poisoning (14,15,16).

 

Recommendations

Food intake results in reduced bioavailability of lipoic acid (2). Therefore, it has been recommended to take up the compound 30 minutes before a meal or 2 hours afterward.  In diabetic patients gastric emptying is usually delayed. In insulin-dependent diabetics, delayed gastric emptying had no substantial influence on lipoic acid bioavailability (12).


References:
  1. Breithaupt-Grögler K, Niebch G. Schneider E, Erb K, Hermann R, Blume HH, Schug BS, Belz GG. Dose-proportionality of oral thioctic acid—coincidence of assessments via pooled plasma and individual data. Eur J Pharmaceut Sci 1999; 8:57-65.
  2. Gleiter CH, Schug BS, Hermann R, Eize M, Blume HH, Gundert-Remy U. Influence of food intake on the bioavailability of thioctic acid enantiomers [letter]. Eur J Clin Pharmacol 1996; 50:513-514.
  3. Hermann R, Niebch G. Human pharmacokinetics of alpha-lipoic acid. In: Packer L, Cadenas E, eds. Biothiols in Health and Disease. New York: Marcel Dekker, 1997; 337-360.
  4. Hermann R, et al. Enantioselective pharmacokinetics and bioavailabilily of different racemic alpha-lipoic acid formulations in healthy volunteers. Eur J Pharmaceut Sci 1996; 4:167-174.
  5. Teichert J, Kern J, Tritschler HJ, Ulrich H, Preiss R. Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int J Clin Pharmacol Therapeut 1998; 36:625-628.
  6. Sen CK. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 1998; 55:1747-1758.
  7. Barnes PJ, Karin M. Nuclear factor-?B—a pivotal transcription factor in chronic inflammatory diseases. N EngI J Med 1997; 336:1066-1071.
  8. Packer L. Alpha-Lipoic Acid: a metabolic antioxidant which regulates NF-kappa ß signal transduction and protects against oxidative injury. Drug Metabol Rev 1998;30:245-275.
  9. Schulze-Osthoff K, Los M, Baeuerle PA. Redox signalling by transcription factors NF-?B and AP-1 in lymphocytes. Biochem Pharmacol 1995; 50:735-741.
  10. Suzuki YJ, Aggarwal BB, Packer L. alpha-lipoic acid is a potent inhibitor of NF-?B activation in human T cells. Biochem Biophys ResCommun 1994; 1S9:1709-1715.
  11. Suzuki YJ, Packer L, Mizuno M, Ulrich H. Regulation of gene expression by lipoic acid. In: Packer I., Cadenas I:, eds. Biothiols in Health and Disease. New York:Marcel Dekker, 1995:455-466.
  12. Hermann R, Wildgrube HJ, Ruus P, Niebch G, Nowak H, Gleiter CH. Gastric emptying in patients with insulin dependent diabetes mellitus and bioavailability of thioctic acid-enantiomers. Eur J Pharmaceut Sci 1998; 6:27-37.
  13. Packer L, Witt EH, Tritschler HJ, Wessel K, Ulrich H. Antioxidant properties and clinical implications of alpha -lipoic acid. In: Packer L, Cadenas E, eds. Biothiols in Health and Disease. New York: Marcel Dekker, 1995:479-516.
  14. Anuradha B, Varalakshmi P. Protective role of alpha-lipoic acid against mercury-induced neural lipid peroxidation. Pharmacol Res 1999; 39:67-80.
  15. Gregus Z, Stein AF, Varga F, Klaassen CD. Effect of lipoic acid on biliary excretion of glutathione and metals. Toxicol AppI Pharmacol 1992; 114:88-96.
  16. Ou P, Tritschler HJ, Wolff SP. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem Pharmacol 1995; 50:123-126.
  17. Constantinescu A, Han D, Packer 1-. Vitamin E recycling in human erythrocyte membranes. J Biol Chem 1993; 268:10906-10913.
  18. Kozlov AV, Gille L, Staniek K, Nohl H. Dihydrolipoic acid maintains ubiquinone in the antioxidant active form by two-electron reduction of ubiquinone and one-electron reduction of ubisemiquinone. Arch Biochem Biophys 1999; 363:148-154.
  19. Podda M, Tritschler HJ, Ulrich H, Packer L. alpha-Lipoic acid supplementation prevents symptoms of vitamin E deficiency. Biochem Biophys Res Commun 1994; 204:98-104.
  20. Busse E, Zimmer G, Schopohl B, Kornhuber B. Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneim-Forsch/Drug Res 1992; 42:829-832.
  21. Han D, Handelman G, Marcocci L, Sen CK, Roy S, Kobuchi H, Flohe L, Packer L. Lipoic acid increases de novo synthesis of cellular glutathione by improving cysteine utilization. Biofactors 1997; 6:321-338.
  22. Sen CK, Roy S, Han D, Packer L. Regulation of cellular thiols on human lymphocytes by alpha-lipoic acid. Free Rad Biol Med 1997; 22:1241-1257.
  23. Sen CK, Roy S, Packer L. Alpha-Lipoic acid: cell regulatory function and potential therapeutic implications. In; Packer L, Hiramatsu M, Yoshikawa T, eds. Antioxidant Food Supplements in Human Health. San Diego: Academic Press, 1999:111-119.


*** Your Title Here ***
home catalouge client archive contact



Click HERE to to join our Mailing List for updates


Website Design by BRAULER
webmaster@brauler.com
This page was last updated 11/15/2002